Skip to main content
eScholarship
Open Access Publications from the University of California

Ocrelizumab-induced psoriasiform dermatitis in a patient with multiple sclerosis

  • Author(s): Darwin, Evan
  • Romanelli, Paolo
  • Lev-Tov, Hadar
  • et al.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License
Abstract

Multiple Sclerosis (MS) is a chronic autoimmune disease that presents with a wide variety of sensory and motor deficiencies. New medications targeting B cells have been approved to treat MS, but the side effect profile has not been widely explored. Herein, we report a case of drug-induced psoriasiform dermatitis following ocrelizumab treatment. Physicians should be cognizant of this possible side effect in patients receiving treatment for MS.

Main Content
Current View